Access cutting-edge advanced melanoma treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access advanced melanoma specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced melanoma treatment provided free
This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma.
Sponsor: Immunocore Ltd
Check if you qualify for this advanced melanoma clinical trial in Los Angeles, CA
If you're searching for advanced melanoma treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.